Listed by the USPTO as AEDER, SEAN E
Tech Center 1600 • Art Units: 1600 1642 1652 1654 1671
This examiner grants 57% of resolved cases
AEDER, SEAN E has 1,435 resolved cases in tech center 1600 and art unit 1600. The allowance rate is 56.9%, and the interview lift is 20.0%. The median time to allowance is 1,124 days. The large resolved-case volume makes the allowance result a useful planning reference, while the interview association supports using examiner discussions selectively.
Novartis AG, Bristol-Myers Squibb Company, and Biontech SE are the leading companies. CASIMIR JONES, S.C., EpiMED LLC, and Fox Rothschild, LLP are the leading firms. Practitioners may focus interviews on clarifying claim scope and technical distinctions, with written responses carrying the principal burden.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17918479 | TARGETING ABCB5 IN GLIOBLASTOMA MULTIFORME | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 18359569 | LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS | Non-Final OA | The Regents of the University of California |
| 18720518 | METHODS OF USING AN ANTI-AMYLOID BETA PROTOFIBRIL ANTIBODY AND ANTI-TAU ANTIBODY | Non-Final OA | WASHINGTON UNIVERSITY |
| 18528327 | NATURAL KILLER T CELL LIGAND LOADED EXTRACELLULAR NANOVESICLE AND AUTOLOGOUS ANTI-CANCER VACCINE FOR HEMATOLOGIC MALIGNANCIES COMPRISING THE SAME | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18286721 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME | Non-Final OA | BIOGEN MA INC. |
| 17802799 | DPP3 FOR THERAPY GUIDANCE, MONITORING AND STRATIFICATION OF NT-ADM ANTIBODIES IN PATIENTS WITH SHOCK | Final Rejection | 4TEEN4 PHARMACEUTICALS GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy56.9% of resolved applications examined by Sean E Aeder were allowed (1,435 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +20.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sean E Aeder took 1,124 days on average from filing to allowance.
Sean E Aeder examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
